Carmine N. Stengone's Net Worth
$0
Who is Carmine N. Stengone?
Carmine N. Stengone does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include KIORA PHARMACEUTICALS INC, and Contineum Therapeutics, Inc..
SEC CIK
Carmine N. Stengone's CIK is 0001861519
Past Insider Trading and Trends
2024 was Carmine N. Stengone's most active year for acquiring shares with 2 total transactions. Carmine N. Stengone's most active month to acquire stocks was the month of April. 2024 saw Carmine N. Stengone paying a total of $0.00 for 286,778 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
KIORA PHARMACEUTICALS INC (KPRX) Snapshot price: $3.61
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.25K |
$3.68 | $4,600.00 | 1.25K |
Sep 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Contineum Therapeutics, Inc. No price found
CEO and President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |